Plecanatide · source year
19 selected, source-linked Plecanatide records carrying a 2019 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
19 selected records.
3 represented types.
19 distinct public records.
Cited chronology
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT01982240 at 2026-07-30T20:42:14.439Z. Its registry update date was 2019-12-26, and PeptideScanner's reviewed identity mapping was plecanatide.
Source: ClinicalTrials.gov ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 31575291 at 2026-07-30T20:44:20.978Z. PubMed recorded a metadata revision date of 2019-11-22 and an Entrez history date of 2019-10-03. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT03551873 at 2026-07-30T20:43:27.317Z. Its registry update date was 2019-11-22, and PeptideScanner's reviewed identity mapping was plecanatide.
Source: ClinicalTrials.gov ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 29276262 at 2026-07-30T20:44:20.511Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2017-12-26. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Regulatory
DailyMed lists Structured Product Labeling version 4 for the reviewed Plecanatide label family with a published date of 2019-11-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Regulatory
DailyMed lists Structured Product Labeling version 3 for the reviewed Plecanatide label family with a published date of 2019-11-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT03120520 at 2026-07-30T20:44:36.699Z. Its registry update date was 2019-10-04, and PeptideScanner's reviewed identity mapping was plecanatide.
Source: ClinicalTrials.gov ↗
Regulatory
The Federal Register published notice 2019-20108, attributed to FDA and its parent HHS department, on 2019-09-17. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Plecanatide.
Source: Federal Register via GovInfo ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 30014100 at 2026-07-30T20:48:25.280Z. PubMed recorded a metadata revision date of 2019-08-13 and an Entrez history date of 2018-07-18. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 29545635 at 2026-07-30T20:48:25.273Z. PubMed recorded a metadata revision date of 2019-08-06 and an Entrez history date of 2018-03-17. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Regulatory
DailyMed lists Structured Product Labeling version 2 for the reviewed Plecanatide label family with a published date of 2019-07-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT01919697 at 2026-07-30T20:48:52.437Z. Its registry update date was 2019-07-02, and PeptideScanner's reviewed identity mapping was plecanatide.
Source: ClinicalTrials.gov ↗
Regulatory
DailyMed lists Structured Product Labeling version 1 for the reviewed Plecanatide label family with a published date of 2019-06-19. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT02387359 at 2026-07-30T20:50:35.893Z. Its registry update date was 2019-06-14, and PeptideScanner's reviewed identity mapping was plecanatide.
Source: ClinicalTrials.gov ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT02493452 at 2026-07-30T20:50:35.872Z. Its registry update date was 2019-06-14, and PeptideScanner's reviewed identity mapping was plecanatide.
Source: ClinicalTrials.gov ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 29343131 at 2026-07-30T20:51:54.923Z. PubMed recorded a metadata revision date of 2019-06-13 and an Entrez history date of 2018-01-19. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT01429987 at 2026-07-30T20:52:10.191Z. Its registry update date was 2019-05-28, and PeptideScanner's reviewed identity mapping was plecanatide.
Source: ClinicalTrials.gov ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT01722318 at 2026-07-30T20:52:10.190Z. Its registry update date was 2019-05-28, and PeptideScanner's reviewed identity mapping was plecanatide.
Source: ClinicalTrials.gov ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 28506401 at 2026-07-30T20:55:52.312Z. PubMed recorded a metadata revision date of 2019-03-20 and an Entrez history date of 2017-05-17. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗